GC
ESPR

Guggenheim Capital’s Esperion Therapeutics ESPR Stock Holding History

Guggenheim Capital’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-46,985
Closed -$2.08M – 2224
2018
Q3 		$2.08M Sell
46,985
-76
-0.2% -$3.49K 0.01% 1219
2018
Q2 		$1.84M Buy
47,061
+11,547
+33% +$583K 0.01% 1299
2018
Q1 		$2.57M Sell
35,514
-4,014
-10% -$295K 0.01% 1454
2017
Q4 		$2.6M Sell
39,528
-15,567
-28% -$838K 0.01% 1467
2017
Q3 		$2.76M Buy
55,095
+3,428
+7% +$165K 0.01% 1439
2017
Q2 		$2.39M Buy
+51,667
New +$1.9M 0.01% 1506
2015
Q4 		– Sell
-8,496
Closed -$200K – 3012
2015
Q3 		$200K Sell
8,496
-30,993
-78% -$1.95M ﹤0.01% 2735
2015
Q2 		$3.23M Buy
+39,489
New +$3.87M 0.01% 1406

Other funds holding ESPR

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return